Wall Street Journal · Georgia Wells ·

A look at OpenAI-backed Red Queen Bio, an AI biosecurity startup that raised $36M to design antibody drugs against pathogens, including AI-enabled bioweapons

Red Queen Bio is using artificial intelligence to design antibody drugs for novel pathogens

In this story OpenAI Red Queen Bio

A look at OpenAI-backed Red Queen Bio, an AI biosecurity startup that raised $36M to design antibody drugs against pathogens, including AI-enabled bioweapons

Lead Source

Wall Street Journal — A look at OpenAI-backed Red Queen Bio, an AI biosecurity startup that raised $36M to design antibody drugs against pathogens, including AI-enabled bioweapons ↗

How this story grew

Coverage · 0 Discussion · 0

6:03 AM12:03 PM UTC

Discussion

Related stories

Financial Times: Frontier AI labs are stepping up biological risk testing, which is harder than cybersecurity testing, where capabilities can be tested in digital environments

SecurityWeek: London- and Boston-based Mindgard, which offers automated AI security and red-teaming tools to help organizations secure AI systems, raised a $30M Series A

CTech: Air Security, which builds a security service for extensions and other tools installed on AI agents, emerges from stealth with $50M led by Sequoia and Greenoaks

Wall Street Journal: Network Bio, which is developing an AI foundation model from datasets of patient tissue and blood samples created by pooling access to biobanks, raised $50M

GeekWire: Resect AI, which is developing open-source tech to catch AI hallucinations before they happen, emerges from stealth with $25M from private equity investors

Discuss with AI

ChatGPT ↗ Claude ↗

← Back to TechSnif